Yuhan Corporation (000105.KS)

KRW 101900.0

(-3.04%)

Long Term Debt Summary of Yuhan Corporation

  • Yuhan Corporation's latest annual long term debt in 2023 was 60.23 Billion KRW , up 1670.36% from previous year.
  • Yuhan Corporation's latest quarterly long term debt in 2024 Q1 was 78.65 Billion KRW , down 0.0% from previous quarter.
  • Yuhan Corporation reported annual long term debt of 3.4 Billion KRW in 2022, down -89.57% from previous year.
  • Yuhan Corporation reported annual long term debt of 32.62 Billion KRW in 2021, down -36.07% from previous year.
  • Yuhan Corporation reported quarterly long term debt of 78.65 Billion KRW for 2024 Q1, down 0.0% from previous quarter.
  • Yuhan Corporation reported quarterly long term debt of - KRW for 2023 Q4, down -100.0% from previous quarter.

Annual Long Term Debt Chart of Yuhan Corporation (2023 - 2007)

Historical Annual Long Term Debt of Yuhan Corporation (2023 - 2007)

Year Long Term Debt Long Term Debt Growth
2023 60.23 Billion KRW 1670.36%
2022 3.4 Billion KRW -89.57%
2021 32.62 Billion KRW -36.07%
2020 51.02 Billion KRW 2.76%
2019 49.65 Billion KRW -29.28%
2018 70.21 Billion KRW -39.13%
2017 115.33 Billion KRW -17.76%
2016 140.25 Billion KRW 63.08%
2015 86 Billion KRW 256.85%
2014 24.1 Billion KRW 30.27%
2013 18.5 Billion KRW 0.0%
2012 - KRW 0.0%
2011 - KRW 0.0%
2010 - KRW -100.0%
2009 1.4 Billion KRW -43.09%
2008 2.46 Billion KRW -30.11%
2007 3.52 Billion KRW 0.0%

Peer Long Term Debt Comparison of Yuhan Corporation

Name Long Term Debt Long Term Debt Difference
Yuyu Pharma, Inc. 13.64 Billion KRW -341.595%
Dong-A Socio Holdings Co., Ltd. 202.06 Billion KRW 70.19%
Ildong Holdings Co., Ltd. 29.87 Billion KRW -101.608%
HANDOK Inc. 123.78 Billion KRW 51.338%
Kukje Pharma Co., Ltd. 475.74 Million KRW -12560.993%
Dong-A ST Co., Ltd. 161.99 Billion KRW 62.817%
SAMSUNG PHARM. Co., LTD. 101.81 Million KRW -59058.386%
Hanmi Pharm. Co., Ltd. 82.02 Billion KRW 26.57%
Hanall Biopharma Co.,Ltd 590.3 Million KRW -10103.765%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW -895.599%
Dong Sung Bio Pharm.Co.,Ltd. 18.52 Billion KRW -225.194%
MYUNGMOON Pharm co.,Ltd 12.58 Billion KRW -378.646%
Hana Pharm Co., Ltd. 1.59 Billion KRW -3667.328%
Yuyu Pharma, Inc. 13.64 Billion KRW -341.595%
Ilsung Pharmaceuticals Co., Ltd. 119.67 Million KRW -50229.685%
REYON Pharmaceutical Co., Ltd. 121 Billion KRW 50.22%
Aprogen pharmaceuticals,Inc. 32 Billion KRW -88.231%
JW Holdings Corporation 20.65 Billion KRW -191.585%
Ildong Pharmaceutical Co., Ltd. 14.82 Billion KRW -306.294%
Chong Kun Dang Pharmaceutical Corp. 30 Billion KRW -100.779%
JW Pharmaceutical Corporation 30 Billion KRW -100.779%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW -27408.9%
Hyundai Pharmaceutical Co., Ltd. 580.64 Million KRW -10273.575%
Samil Pharmaceutical Co.,Ltd 49.56 Billion KRW -21.516%
Jeil Pharmaceutical Co.,Ltd 4.45 Billion KRW -1252.958%
Yuyu Pharma, Inc. 13.64 Billion KRW -341.595%
Kwang Dong Pharmaceutical Co., Ltd. 19.02 Billion KRW -216.559%
Daewoong pharmaceutical Co.,Ltd 93.41 Billion KRW 35.521%
JW Pharmaceutical Corporation 30 Billion KRW -100.779%
Yuhan Corporation 60.23 Billion KRW 0.0%
Jeil Pharma Holdings Inc 10.5 Billion KRW -473.655%
Yungjin Pharm. Co., Ltd. 40.37 Billion KRW -49.175%
Suheung Co., Ltd. 74 Billion KRW 18.611%
JW Pharmaceutical Corporation 30 Billion KRW -100.779%
Samjin Pharmaceuticals Co., Ltd. 4.16 Billion KRW -1345.62%
Korea United Pharm Inc. 10.96 Billion KRW -449.453%
CKD Bio Corp. 69.43 Billion KRW 13.247%
Daewon Pharmaceutical Co., Ltd. 34.57 Billion KRW -74.213%
Dongwha Pharm.Co.,Ltd 16.12 Billion KRW -273.481%
Whan In Pharm Co.,Ltd. 307.05 Million KRW -19516.526%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW -27408.9%
Chong Kun Dang Holdings Corp. 72.11 Billion KRW 16.472%
Boryung Corporation 151.7 Billion KRW 60.296%
Bukwang Pharmaceutical Co., Ltd. 78.52 Billion KRW 23.294%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW -895.599%
JW Lifescience Corporation 168 Million KRW -35753.43%